ML18318A005: Difference between revisions
Jump to navigation
Jump to search
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
| Line 2: | Line 2: | ||
| number = ML18318A005 | | number = ML18318A005 | ||
| issue date = 11/14/2018 | | issue date = 11/14/2018 | ||
| title = 14-19 Acknowledgement Letter to Congressman Buddy Carter - Categories of Radiopharmaceuticals | | title = 11-14-19 Acknowledgement Letter to Congressman Buddy Carter - Categories of Radiopharmaceuticals | ||
| author name = Dacus E | | author name = Dacus E | ||
| author affiliation = NRC/OCA | | author affiliation = NRC/OCA | ||
Revision as of 20:30, 22 April 2019
| ML18318A005 | |
| Person / Time | |
|---|---|
| Issue date: | 11/14/2018 |
| From: | Eugene Dacus Office of Congressional Affairs |
| To: | Carter B US HR (House of Representatives) |
| Shared Package | |
| ML18313A126 | List: |
| References | |
| LTR-18-0436 | |
| Download: ML18318A005 (1) | |
Text
UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 November 14, 2018 The Honorable Buddy Carter United States House of Representatives Washington, DC 20515 Dear Congressman Carter: This is to acknowledge receipt of your e-mail dated November 8, 2018, regarding training and experience requirements for different Categories of Radiopharmaceuticals; specifically, the geographic disparities and challenges in rural populations.
Please be assured that we are working on a response, and a reply will be forwarded to you as soon as possible.
Sincerely, Eugene Dacus, Director Office of Congressional Affairs